Winslow Asset Management Inc Bio Rad Laboratories, Inc. Transaction History

Winslow Asset Management Inc

  • $502 Million
  • Q4 2024

A detailed history of Winslow Asset Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Winslow Asset Management Inc holds 24,220 shares of BIO stock, worth $8.29 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares
24,220
Previous 24,262 0.17%
Holding current value
$8.29 Million
Previous $8.12 Million 1.98%
% of portfolio
1.59%
Previous 1.5%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$313.15 - $374.28 $13,152 - $15,719
-42 Reduced 0.17%
24,220 $7.96 Million
Q3 2024

Nov 04, 2024
BUY
$263.97 - $344.64 $101,628 - $132,686
385 Added 1.61%
24,262 $8.12 Million
Q2 2024

Aug 09, 2024
BUY
$268.26 - $339.48 $294,549 - $372,749
1,098 Added 4.82%
23,877 $6.52 Million
Q1 2024

May 02, 2024
BUY
$304.11 - $351.99 $219,871 - $254,488
723 Added 3.28%
22,779 $7.88 Million
Q4 2023

Feb 16, 2024
BUY
$269.37 - $365.04 $165,123 - $223,769
613 Added 2.86%
22,056 $7.12 Million
Q3 2023

Nov 07, 2023
BUY
$350.25 - $422.63 $198,942 - $240,053
568 Added 2.72%
21,443 $7.69 Million
Q2 2023

Aug 09, 2023
BUY
$359.49 - $486.4 $284,716 - $385,228
792 Added 3.94%
20,875 $7.91 Million
Q1 2023

May 03, 2023
SELL
$418.69 - $503.0 $95,461 - $114,684
-228 Reduced 1.12%
20,083 $9.62 Million
Q4 2022

Jan 23, 2023
BUY
$351.71 - $456.01 $528,268 - $684,927
1,502 Added 7.99%
20,311 $8.54 Million
Q3 2022

Nov 08, 2022
BUY
$412.59 - $563.26 $68,902 - $94,064
167 Added 0.9%
18,809 $7.85 Million
Q2 2022

Aug 03, 2022
BUY
$463.67 - $597.16 $163,211 - $210,200
352 Added 1.92%
18,642 $9.23 Million
Q1 2022

May 09, 2022
SELL
$524.57 - $735.42 $148,453 - $208,123
-283 Reduced 1.52%
18,290 $10.3 Million
Q4 2021

Feb 07, 2022
BUY
$708.84 - $794.68 $27,644 - $30,992
39 Added 0.21%
18,573 $14 Million
Q3 2021

Nov 12, 2021
SELL
$657.71 - $825.77 $371,606 - $466,560
-565 Reduced 2.96%
18,534 $13.8 Million
Q2 2021

Aug 10, 2021
SELL
$576.64 - $649.04 $8,649 - $9,735
-15 Reduced 0.08%
19,099 $12.3 Million
Q1 2021

May 10, 2021
SELL
$547.01 - $662.35 $1.04 Million - $1.27 Million
-1,910 Reduced 9.08%
19,114 $10.9 Million
Q4 2020

Feb 01, 2021
SELL
$510.68 - $643.45 $219,081 - $276,040
-429 Reduced 2.0%
21,024 $12.3 Million
Q3 2020

Nov 10, 2020
SELL
$454.43 - $535.6 $406,714 - $479,362
-895 Reduced 4.0%
21,453 $11.1 Million
Q2 2020

Aug 11, 2020
SELL
$334.87 - $493.06 $64,295 - $94,667
-192 Reduced 0.85%
22,348 $10.1 Million
Q1 2020

May 12, 2020
BUY
$320.01 - $409.07 $77,762 - $99,404
243 Added 1.09%
22,540 $7.9 Million
Q4 2019

Feb 10, 2020
SELL
$319.73 - $374.2 $3,517 - $4,116
-11 Reduced 0.05%
22,297 $8.25 Million
Q3 2019

Nov 12, 2019
SELL
$304.55 - $345.24 $1.11 Million - $1.26 Million
-3,657 Reduced 14.08%
22,308 $7.42 Million
Q2 2019

Jul 29, 2019
SELL
$286.93 - $312.59 $406,005 - $442,314
-1,415 Reduced 5.17%
25,965 $8.12 Million
Q1 2019

May 10, 2019
SELL
$224.3 - $317.41 $55,402 - $78,400
-247 Reduced 0.89%
27,380 $8.37 Million
Q4 2018

Feb 13, 2019
SELL
$220.1 - $309.0 $48,422 - $67,980
-220 Reduced 0.79%
27,627 $6.42 Million
Q3 2018

Oct 18, 2018
SELL
$289.28 - $326.15 $124,101 - $139,918
-429 Reduced 1.52%
27,847 $8.72 Million
Q2 2018

Jul 13, 2018
BUY
$244.1 - $303.88 $79,332 - $98,761
325 Added 1.16%
28,276 $8.16 Million
Q1 2018

Apr 26, 2018
SELL
$233.97 - $274.11 $21,291 - $24,944
-91 Reduced 0.32%
27,951 $6.99 Million
Q4 2017

Jan 11, 2018
BUY
$216.94 - $271.3 $241,237 - $301,685
1,112 Added 4.13%
28,042 $6.69 Million
Q3 2017

Oct 13, 2017
BUY
$212.27 - $242.28 $5.72 Million - $6.52 Million
26,930
26,930 $5.98 Million

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.7M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Winslow Asset Management Inc Portfolio

Follow Winslow Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email